Validation of New Virtual Reality Treatment for Children With Lazy Eye Using the Vedea Amblyopia Therapy (VAT)

NAActive, not recruitingINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

February 22, 2023

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2024

Conditions
Amblyopia, AnisometropicAmblyopia StrabismicAmblyopia
Interventions
DEVICE

Vedea Amblyopia Therapy (VAT)

Children will use the VAT for 5 days per week, 30 minutes per day. They play VR-games using a VR-headset, which content is optimized for dichoptic training.

DEVICE

Occlusion therapy

Children are given an eye patch to occlude their dominant eye with for a prescribed number of hours per day. This may typically range anywhere between 2-8 hours per day, depending on the severity of the amblyopia.

Trial Locations (2)

5223 GZ

Jeroen Bosch Ziekenhuis, 's-Hertogenbosch

3011 BH

The Rotterdam Eye Hospital, Rotterdam

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Health Holland

OTHER

collaborator

Oogziekenhuis Rotterdam

OTHER

collaborator

Rotterdams Oogheelkundig Instituut

UNKNOWN

collaborator

Elisabeth-TweeSteden Ziekenhuis

OTHER

collaborator

Jeroen Bosch Ziekenhuis

OTHER

lead

Vedea Healthware BV

INDUSTRY

NCT05620173 - Validation of New Virtual Reality Treatment for Children With Lazy Eye Using the Vedea Amblyopia Therapy (VAT) | Biotech Hunter | Biotech Hunter